I

ICH Study Center GmbH & Co. KG | Hamburg, Germany

Research site

(Unclaimed)

Location

Grindelallee 35, Hamburg, Hamburg, Germany

Site insights

Top conditions

Top treatments

JNJ-56136379

Bictegravir

Lenacapavir

JNJ-73763989

TAF

GS-6207

Entecavir

TDF

Tenofovir disoproxil fumarate

Tenofovir alafenamide

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 9 total trials

Locations recently updated

DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053)

This is a randomized, active-controlled, double-blind clinical study designed to evaluate the antiretroviral activity, safety, and tolerability of do...

Enrolling

HIV-1 Infection

Drug: BIC/FTC/TAF

Drug: Placebo to DOR/ISL

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen (ARTISTRY-1)

The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC) plus lenacapavir (LEN), versus...

Enrolling

HIV-1-infection

Drug: Stable Baseline Regimen

Drug: Bictegravir

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance (CAPELLA)

The primary objective of this study is to evaluate the antiviral activity of lenacapavir (formerly GS-6207) administered as an add-on to a failing re...

Active, not recruiting

HIV-1-infection

Drug: Optimized Background Regimen (OBR)

Drug: Oral Lenacapavir Placebo

The Late Presenter Treatment Optimisation Study (LAPTOP)

The main purpose of this study is to compare two different types of HIV treatments, in terms of effectiveness and improvement of side effects, for pa...

Active, not recruiting

HIV/AIDS

Drug: Biktarvy

Drug: Symtuza